Mainstay Medical is an Irish medical technology company aiming to treat chronic non-specific low back pain by using their active implantable device, the ReActiv8
Mainstay raised €30m by completing a direct private placement of 2.3m shares at €13 per share
KCK Ltd., a family investment fund, participated as cornerstone investor, subscribing for €15m
Kempen & Co acted as Financial Adviser and Coordinating Placement Agent in the transaction